Delivery Order SPE2DB22D3301-SPE2DB25FY7VM
Award Date 7/15/25
Potential Completion Date 7/16/25
Potential Value $2.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Humira (adalimumab) 40 mg/0.4 mL syringes, a biologic medication used to treat various autoimmune conditions. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $3,398.85 and a performance period ending on April 17, 2025. AmerisourceBergen Drug Corp holds...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Humira (adalimumab), a prescription medication used to treat various autoimmune conditions. The contract has a ceiling value of $43,341.96 and a period of performance through April 30, 2025. It is a firm-fixed-price, non-set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Humira (CF) 40 mg/0.4 mL medication, with a ceiling value of $5,811.50 and a performance period through April 2025. The contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $73,538.70 and is for the supply of Humira (adalimumab) 40 mg/0.4 mL auto-injector pens. The contract has a performance period through January 17, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Humira (adalimumab) 40 mg/0.4 mL medication. The contract has a firm-fixed price of $1,764.52 and a completion date of September 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,823.32, is for the delivery of Humira (adalimumab) 40 mg/0.4 mL, a biologic medication used to treat various autoimmune conditions. The contract is a firm-fixed-price delivery order with a period of performance through May 8, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a delivery order under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Humira (adalimumab) 40 mg/0.4 mL medication, a specialty pharmaceutical used to treat various autoimmune conditions. The $21,183.13 firm fixed-price delivery order has a period of performance through September 2023. The DLA IDC, valued at $999,999,999, serves as the primary contracting...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,163.19 firm fixed-price contract is for the delivery of Humira 40 mg/0.8 ml syringes, a medication used to treat various autoimmune conditions. The contract has a period of performance through June 25, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Humira (CF) Pen 40 mg/0.4 mL medication, a specialty drug used to treat various autoimmune conditions. The contract has a ceiling value of $16,379.85 and an ultimate completion date of January 17, 2024. The contract is a firm fixed-price, delivery order type, with no set-aside...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a medication used to treat various medical conditions. The contract has a ceiling value of $2,716.48 and a period of performance through July 16, 2025. The award is not a set-aside contract, indicating open competition....